These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35199517)

  • 1. Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses.
    Freitas BT; Ahiadorme DA; Bagul RS; Durie IA; Ghosh S; Hill J; Kramer NE; Murray J; O'Boyle BM; Onobun E; Pirrone MG; Shepard JD; Enos S; Subedi YP; Upadhyaya K; Tripp RA; Cummings BS; Crich D; Pegan SD
    ACS Infect Dis; 2022 Mar; 8(3):596-611. PubMed ID: 35199517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
    Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
    J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
    Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
    ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
    Lindner HA; Fotouhi-Ardakani N; Lytvyn V; Lachance P; Sulea T; Ménard R
    J Virol; 2005 Dec; 79(24):15199-208. PubMed ID: 16306591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses.
    Deng X; Agnihothram S; Mielech AM; Nichols DB; Wilson MW; StJohn SE; Larsen SD; Mesecar AD; Lenschow DJ; Baric RS; Baker SC
    J Virol; 2014 Oct; 88(20):11825-33. PubMed ID: 25100850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
    Ratia K; Kilianski A; Baez-Santos YM; Baker SC; Mesecar A
    PLoS Pathog; 2014 May; 10(5):e1004113. PubMed ID: 24854014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.
    Barretto N; Jukneliene D; Ratia K; Chen Z; Mesecar AD; Baker SC
    J Virol; 2005 Dec; 79(24):15189-98. PubMed ID: 16306590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment.
    Stasiulewicz A; Maksymiuk AW; Nguyen ML; Bełza B; Sulkowska JI
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.
    Békés M; Rut W; Kasperkiewicz P; Mulder MP; Ovaa H; Drag M; Lima CD; Huang TT
    Biochem J; 2015 Jun; 468(2):215-26. PubMed ID: 25764917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site.
    van Vliet VJE; Huynh N; Palà J; Patel A; Singer A; Slater C; Chung J; van Huizen M; Teyra J; Miersch S; Luu GK; Ye W; Sharma N; Ganaie SS; Russell R; Chen C; Maynard M; Amarasinghe GK; Mark BL; Kikkert M; Sidhu SS
    PLoS Pathog; 2022 Dec; 18(12):e1011065. PubMed ID: 36548304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery.
    Amin SA; Ghosh K; Singh S; Qureshi IA; Jha T; Gayen S
    Mol Divers; 2022 Feb; 26(1):215-228. PubMed ID: 33675510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
    Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
    ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities.
    Mielech AM; Kilianski A; Baez-Santos YM; Mesecar AD; Baker SC
    Virology; 2014 Feb; 450-451():64-70. PubMed ID: 24503068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
    Shin D; Mukherjee R; Grewe D; Bojkova D; Baek K; Bhattacharya A; Schulz L; Widera M; Mehdipour AR; Tascher G; Geurink PP; Wilhelm A; van der Heden van Noort GJ; Ovaa H; Müller S; Knobeloch KP; Rajalingam K; Schulman BA; Cinatl J; Hummer G; Ciesek S; Dikic I
    Nature; 2020 Nov; 587(7835):657-662. PubMed ID: 32726803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
    Klemm T; Ebert G; Calleja DJ; Allison CC; Richardson LW; Bernardini JP; Lu BG; Kuchel NW; Grohmann C; Shibata Y; Gan ZY; Cooney JP; Doerflinger M; Au AE; Blackmore TR; van der Heden van Noort GJ; Geurink PP; Ovaa H; Newman J; Riboldi-Tunnicliffe A; Czabotar PE; Mitchell JP; Feltham R; Lechtenberg BC; Lowes KN; Dewson G; Pellegrini M; Lessene G; Komander D
    EMBO J; 2020 Sep; 39(18):e106275. PubMed ID: 32845033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural view and substrate specificity of papain-like protease from avian infectious bronchitis virus.
    Kong L; Shaw N; Yan L; Lou Z; Rao Z
    J Biol Chem; 2015 Mar; 290(11):7160-8. PubMed ID: 25609249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors.
    Valipour M
    Eur J Med Chem; 2022 Oct; 240():114572. PubMed ID: 35797899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
    Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
    J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus.
    Daczkowski CM; Goodwin OY; Dzimianski JV; Farhat JJ; Pegan SD
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.